Govt removes duty anomalies to boost manufacturing of medical devices

A proposal to create a separate pharma ministry is under active consideration of the PMO

Medical devices
Medical catheters
Press Trust of India Bengaluru
Last Updated : Feb 11 2017 | 5:41 PM IST
The government has removed anomalies in the duty structure to boost manufacturing of medical devices, Chemicals and Fertilisers Minister Ananth Kumar said on Saturday.

He also announced setting up of a pharma-cum-medtech zone near Bangalore, while noting that a proposal to create a separate pharma ministry is under active consideration of the PMO.

Further, the minister assured the industry a transparent and predictable drug price regime and called upon the companies to provide quality drugs at affordable rates to all section of the society.

"I would like to thank Prime Minister and Finance Minister for correction of inverted duty structure to give level playing field to medical devices sector. It is a big thing. It has already been done," Kumar said addressing the three-day 'India Pharma 2017' event organised by the central government along with industry body Ficci.

An inverted duty structure impacts the domestic industry adversely as inputs and raw materials are taxed at a higher rate than import duty on finished products.

The medical industry has been demanding the removal of duty anomalies for many years.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 11 2017 | 5:40 PM IST

Next Story